Sports Analytics Market to Witness Exponential Growth by 2030: Grand View Research Inc.

 Sports Analytics Market Growth & Trends

The global sports analytics market size is expected to reach USD 6.34 billion by 2030, registering a compound annual growth rate (CAGR) of 27.1% from 2022 to 2030, according to a new report by Grand View Research, Inc. the increasing preference for data in decision making by various associations and organizations is expected to fuel the market growth. The managers and coaches use sports analytics solutions to gain multiple parameters, in-depth analysis, and the players' performance and design training sessions using collected insights. The solutions offer predictive analysis to study the physical parameters of players to prevent injuries that might happen in the future.

The sports industry produces large volumes of information in raw data that does not provide clear insights. However, if the data is processed further, it can provide valuable insights about the entire team and individual players. The sports analytics solutions help analyze the raw data and provide essential insights in real-time using graphical interfaces. The sports analytical tool helps to analyze the data such as the history of the opponents, line-up of players, win and loss records, and various player metrics, including distance covered, speed, stamina, acceleration, and energy levels. Moreover, insights can also be shared with managers, coaches, and fantasy gaming applications.

The leading associations and teams have already implemented sports analytical solutions and have hired professional analysts to improve the team and individual performance by obtaining valuable insights and gaining a competitive edge over opponents on and off the field. The associations such as National Basketball Association (NBA), Royal Spanish Football Federation, German Football Association, and many others have already deployed analytical tools to determine the results of future game events.

Teams have also adopted sports analytics solutions to analyze the players' fitness, overall performance, and engagement with fans. For instance, in December 2021, TRAM Barcelona Open and wheelchair tennis partnered with IBM Corporation. The partnership has helped TRAM Barcelona Open elevate its status in International Tennis Federation by enhancing the overall tournament experience, improving brand visibility, and increased audience engagement by using IBM cloud connect and IBM Watson Assistant, which are used in numerous other tournaments like the US Open and Wimbledon.

Request a free sample copy or view the report summary: Sports Analytics Market Report

Sports Analytics Market Report Highlights

• The football segment is expected to witness the highest CAGR growth during the forecast period in the sports segment, owing to the faster adoption of the latest technologies and heavy investments done by the teams and associations in the sports analytics market
• In the analysis segment, the On-Field analysis segment is projected to witness the highest CAGR growth in the forecast period, owing to the increasing implementation of sports analytics solutions for Health Assessment, Video Analysis, and players and team analysis in the sports industry
• The software segment is expected to experience the highest growth in the forecast period, owing to the increased popularity of cloud-based sports analytics software, which provides flexibility and accessibility

Access Press Release@ https://www.grandviewresearch.com/press-release/global-sports-analytics-market

Sports Analytics Market Segmentation

Grand View Research has segmented the global sports analytics market based on component, analysis type, sports, and region:

Sports Analytics Component Outlook (Revenue, USD Million, 2018 - 2030)

• Software
• Service

Sports Analytics Type Outlook (Revenue, USD Million, 2018 - 2030)

• On-field
  • Player & Team Analysis
  • Video Analysis
  • Health Assessment
• Off-field
  • Fan Engagement
  • Ticket Pricing

Sports Analytics Outlook (Revenue, USD Million, 2018 - 2030)

• Football
• Cricket
• Baseball
• Basketball
• Rugby
• Others

Sports Analytics Regional Scope (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa (MEA)

List of Key Players in the Sports Analytics Market

• Agile Sports Analytics, LLC
• Catapult
• ChyronHego Corporation
• Deltatre
• Experfy Inc.
• Genius Sports Group
• IBM Corporation
• Oracle Corporation
• SAP SE
• SAS Institute Inc.
• Sportradar AG
• Stats Perform

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

U.S. Digital Therapeutics Market Predicted to Witness Steady Growth During the Forecast Period

 U.S. Digital Therapeutics Market Growth & Trends

The U.S. digital therapeutics market size is anticipated to reach USD 10.5 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a lucrative CAGR of 24.8% from 2022 to 2030. Growing healthcare consumerism, the availability & development of DTx products, and the rising number of market players are driving the regional market.

SparkRx by Limbix Health, for example, is a digital therapeutic that is indicated for the treatment of adolescent depression. It is available without a prescription since the COVID-19 pandemic, under the FDA’s emergency guidance for digital health devices used in the treatment of psychiatric disorders. The COVID-19 pandemic has expedited the adoption of DTx, especially concerning mental illness and chronic ailments like diabetes and CVS. The U.S. FDA released new guidelines for computerized behavioral therapy and other DTx solutions during this public health emergency.

The organization has waived off guidelines that include 510(k) premarket notifications, registration & listing requirements, and Unique Device Identification (UDI) requirements for DTx therapeutic devices with low risk. For instance, Pear therapeutics launched Pear-004 for psychosis and self-management training post the introduction of the new guidelines. The product needs to be used under a doctor’s supervision.

The need for cost-effective healthcare is increasing globally due to rising healthcare expenditure. Digital health technology is being encouraged and preferred to avoid unnecessary costs and promote cheaper, alternative means of healthcare delivery, thus propelling the market. Moreover, the rising demand for remote monitoring services due to the increasing incidences of chronic diseases worldwide is one of the factors propelling the market growth. Digital therapeutic applications allow patients to manage and treat diseases without constant medical intervention, thereby drastically reducing the healthcare expenditure.

Request a free sample copy or view the report summary: U.S. Digital Therapeutics Market Report

U.S. Digital Therapeutics Market Report Highlights

• The digital therapeutics market in the U.S. was valued at USD 1.5 billion in 2021 and is expected to advance at a CAGR of 24.8% during the forecast period
• In terms of revenue, diabetes dominated the application segment in 2021. The growth can be attributed to the increasing incidence of this disease and the rising demand for self-management and constant monitoring
• Digital therapeutics solutions find application in 3 key product categories — products to manage a condition, treat a disease, and improve a health function; as such, the demand for these solutions is expected to increase in the coming years owing to the rising burden of chronic disorders
• Based on end-use, the patient segment held the largest revenue share in 2021, owing to the increased adoption of healthcare IT services through AI-driven smartphone apps
• In the wake of the COVID-19 pandemic, patients with chronic diseases have been facing challenges in managing medications, visiting healthcare providers, and maintaining a balanced diet. DTx therapy can be useful in managing patient conditions remotely
• In January 2020, Pear Therapeutics and Crossroads Treatment Centers entered into a partnership to incorporate reSET-O PDT in several opioid use disorder treatment centers located in Pennsylvania, thereby enhancing its market reach

Access Press Release@ https://www.grandviewresearch.com/press-release/us-digital-therapeutics-market-analysis

U.S. Digital Therapeutics Market Segmentation

Grand View Research has segmented the U.S. digital therapeutics market based on application and end-use:

U.S. Digital Therapeutics Application Outlook (Revenue, USD Million, 2017 - 2030)

• Diabetes
• Obesity
• CVD
• Respiratory Diseases
• Smoking Cessation
• CNS Disease
• Others

U.S. Digital Therapeutics End-use Outlook (Revenue, USD Million, 2017 - 2030)

• Patients
• Providers
• Payers
• Employers
• Others

List of Key Players in the U.S. Digital Therapeutics Market

• Omada Health Inc.
• Teladoc Health, Inc.
• 2Morrow Inc.
• Propeller Health (ResMed)
• Fitbit Health Solutions
• Canary Health
• WellDoc, Inc.
• Noom, Inc.
• Pear Therapeutics, Inc.
• Click Therapeutics, Inc.
• Akili Interactive Labs, Inc.
• Better Therapeutics, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Key Insights of Future Prospects of Coronary Stents Market During 2022– 2030: Grand View Research Inc.

 Coronary Stents Market Growth & Trends 

The global coronary stents market size is expected to reach USD 12.1 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 3.3% from 2022 to 2030. Increasing adoption of minimally invasive surgeries and Percutaneous Coronary Intervention (PCI) procedures is expected to drive the market in the coming years. For instance, according to The Korean Journal of Thoracic and Cardiovascular Surgery, the proportion of PCI for Coronary Artery Disease (CAD) was 78% in 2016, and the country-specific PCI proportion was 96%, which was significantly higher than the global average. As a result, the unprecedented growth in CAD incidence, along with an increase in the proportion of PCIs done in these CAD patients, is expected to raise demand for an effective coronary stent technology.

Technological advancement and the launch of 2^nd generation drug-eluting stents are further fueling the growth. For instance, Abbott Laboratories Laboratories' XIENCE Sierra became the first DES approved for CTO indications in the US in May 2018. Medtronic followed suit in early 2019, obtaining FDA approval for the use of its Resolute range of DES in CTO indications. In addition, many companies have recently launched newer versions of their coronary stent systems in the US, notably Boston Scientific's Synergy Megatron in January 2021 and Abbott Laboratories Laboratories' XIENCE Skypoint in June 2021. 

The global COVID-19 pandemic has had a negative impact on the market for coronary stents. According to guidelines from physician societies throughout the world, procedure deferrals primarily impacted less urgent or elective procedures for eligible patients. ACC's ((American College of Cardiology) 2020 guidance, for instance, recommended postponing non-urgent procedures like CTO interventions and surveillance angiography during the peak of the COVID-19 pandemic. These guidelines have influenced physicians' treatment decisions throughout the world. Additionally, according to the European Society of Cardiology recommendations, all emergency and urgent PCI procedures (treatment of STEMI, high or intermediate risk NSTEMI, cardiogenic shock, and unstable angina) should be continued during the peak of the pandemic and in the subsequent resurgence of COVID-19, while only elective PCI procedures (CTO interventions or treatment of NYHA II symptoms) should be deferred.

Moreover, recovery of the coronary stent market from the COVID-19 pandemic is anticipated to be aided by the continuous performance of urgent PCI procedures and an increase in capacity utilization for performing non-elective procedures.

The coronary stent market is driven by reimbursement coverage provided by the general public Center for Medicare & Medicaid Services (CMS) and private payers. The coverage is availed under national coverage determination for carotid artery stenting, including products and service providers. From January 2020, the Centers for Medicare & Medicaid Services (CMS) proposed reimbursement for some angioplasty and stenting procedures performed in the ambulatory surgical centers (ASC), which is expected to boost the market revenue over the forecast period. 

Request a free sample copy or view the report summary: Coronary Stents Market Report

Coronary Stents Market Report Highlights

• Overall PCI procedure volumes treated with coronary stent devices will rise as the aging population and the PCI-eligible patient population grows, owing to new technologies and increased ability to treat severe lesions
• Prices for the first-generation BVS (Bioresorbable Vascular Scaffold) are much high as compared to existing BMS (Bare Metal Stent) and DES (Drug-Eluting Stents). Due to its safety concern and high hospitalization rates, doctors are not preferring BRS over DES
• Favorable clinical trials have demonstrated that DES is better than standard BMS. As a result, in 2021, DES has dominated the market
• Over the forecast period, Asia Pacific is expected to see the highest growth. The market will further increase in the coming years as disposable income rises and the prevalence of heart disease rises
• Furthermore, in cost-constrained nations like India and China, growing government investment in healthcare and new attempts to bring in equipment at cheap rates are also influencing this market
• In June 2020, SMT received nationwide reimbursement for Supraflex Cruz Heart Stent in France to treat individuals with a coronary heart disorder 

Access Press Release@ https://www.grandviewresearch.com/press-release/global-coronary-stent-industry

Coronary Stents Market Segmentation 

Grand View Research has segmented the global coronary stents market report based on product and region:

Coronary Stents Product Outlook (Revenue, USD Million, 2017 - 2030)

• Bare Metal Stents (BMS)
• Drug-Eluting Stents (DES)
  • Biodegradable
  • Non-Biodegradable
• Bioresorbable Vascular Scaffold (BVS)

Coronary Stents Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Some of the Key Players in the Coronary Stents Market

• Abbott
• Medtronic
• Boston Scientific Corporation
• Terumo Corporation
• B Braun Melsungen AG
• Biotronik
• Stentys SA
• MicroPort Scientific Corporation
• R. Bard, Inc.
• Cook Medical

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Healthcare Smart Contract Market is Projected to Boost USD 7.83 Billion by 2030: Grand View Research Inc.

 Healthcare Smart Contract Market Growth & Trends

The global healthcare smart contracts market size is expected to reach USD 7.83 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 20.5% from 2022 to 2030. Key benefits offered by technology such as decentralized management, data provenance, robust data, traceable data drive the market. Increasing businesses demand the requirement to bring revolutionary changes in all the aspects of their businesses as technology and time progress. When it comes to the health care field, the urgency of growth escalates to higher levels. Quality healthcare services supported with the modern technology is the need. Furthermore, the healthcare system landscape is shifting to a more patient-centric approach. Thus, aforementioned factors expected to adopt the smart contract during the forecast period.

Besides, the COVID-19 pandemic has showed the restrictions in existing healthcare systems to handle patient records securely and transparently, and innovative protocols are essential to address such shortcomings. Application of Blockchain technology is gaining traction in healthcare and can alleviate these issues. For instance, a study published in January 2022 demonstrated that securely and quickly storing and retrieving COVID-19-related health information using smart contracts with the Ethereum blockchain allows the patient information protection while enabling more efficient research and communication. Thus, an attractive option of smart contracts to safeguard the storage of medical records and associated data logs will support the market growth.

According to Forbes, pharmaceutical corporations incur an estimated $200 billion annual loss owing to counterfeit drugs globally. Thus, adoption of Smart Contracts technology which is likely to trace drugs over their whole life cycle is expected to boost during the forecast timeline. Moreover, the corporations are utilizing digital technology to mitigate such issues, which in turn, supports market growth. For instance, the solution Merck KGaA are developing offers a framework to produce digital trust by simply transforming human trust in quality control into a more effective machine-to-machine (M2M) interaction. Its new, multi-patented technology, which is built on numerous blockchain layers, digital certificates, crypto anchors, and smart contracts will offer one “single source of truth”.

Request a free sample copy or view report summary: Healthcare Smart Contracts Market Report

Healthcare Smart Contract Market Report Highlights

• Ethereum held the largest revenue share in 2021. This type of blockchain can work with both external owned accounts and internal contract accounts
• Under the application, Supply Chain Management held the major share in 2021. The growth can be attributed to increasing awareness and demand for superior drugs
• Healthcare Payer showed the fastest growing market owing to broad range of technology uses and applications of technology in healthcare
• North America is expected to emerge as the second largest dominating region in this market space. The U.S. is observed to have highest number of companies dealing in this space, which in turn, has contributed to the large share of regional market
• The market is highly competitive in nature. In November 2018, Change Healthcare and TIBCO Software have publicized a partnership to build the first healthcare smart contract system, using the TIBCO's smart contract developer project, “Project Dovetail” and Change Healthcare Intelligent Healthcare Network blockchain technology

Access Press Release@ https://www.grandviewresearch.com/press-release/global-healthcare-smart-contract-market

Healthcare Smart Contract Market Segmentation

Grand View Research has segmented the global Healthcare Smart Contract Market based on blockchain type, application, end-use, and region:

Healthcare Smart Contract Blockchain Type Outlook (Revenue, USD Million, 2017 - 2030)

• Hyperledger Fabric
• MultiChain56
• Ethereum
• Others

Healthcare Smart Contract Application Outlook (Revenue, USD Million, 2017 - 2030)

• Data Exchange and Interoperability
• Clinical Trials
• Supply Chain Management
• Claims Adjudication and Billing Management
• Others

Healthcare Smart Contract End-use Outlook (Revenue, USD Million, 2017 - 2030)

• Healthcare Provider
• Healthcare Payer
• Drug and Medical Device Companies
• Others

Healthcare Smart Contract Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa
  • Saudi Arabia

List of Key Players of the Healthcare Smart Contract Market

• IBM
• ScienceSoft USA Corporation
• Blockchain AI Solutions Ltd (FarmaTrust)
• SmartData Enterprises
• ION Medical Safety
• Aetsoft Inc.
• Apriorit
• ELEKS
• Medicalchain 
• PokitDok

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Veterinary Prosthetics & Orthotics Market Latest Innovations, Drivers and Industry Key Events 2022– 2030: Grand View Research Inc.

 Veterinary Prosthetics & Orthotics Market Growth & Trends

The global veterinary prosthetics & orthotics market size is anticipated to reach USD 68.6 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a significant CAGR of 8.9% from 2022 to 2030. Some of the drivers attributing to the market growth include rising pet dog ownership, the number of veterinary surgeries across the globe, initiatives by key companies, and orthopedic disorders in pet dogs. For injured animals, the use of orthoses (braces) and prostheses is becoming more widespread. Any medical device that is fastened to the body to provision, position, immobilize, prevent or correct deformity, help weak muscles, or increase function is referred to as an orthosis. Prosthetics are also medical devices that are used to replace a missing or severed leg section.

The COVID-19 pandemic led to a decrease in revenue for market players in the veterinary prosthetics & orthotics market. This was due to cancellation or delay in elective surgical procedures during 2020. Other challenges faced by key companies included logistical bottlenecks and dampened demand. The market, however, recovered gradually to pre-COVID numbers during 2021. In addition, the COVID-19 pandemic has catalyzed pet ownership according to findings of the Pet Food Manufacturers Association (PFMA), U.K. This is expected to contribute to market growth. The findings of the two surveys conducted in 2020 by the PFMA during the COVID-19 crisis confirmed a surge in pet ownership in the U.K. Around 3.2 million households or 11% of people brought home a pet since the start of the pandemic.

The market is predicted to rise due to factors such as the increased prevalence of obesity and the growing pet population. According to the American Pet Products Association's (APPA) 2019-2020 National Pet Owners Survey, 67% of households, or about 85 million families, in the U.S. have a pet. Furthermore, there has been a large increase in the worldwide animal population, which is expected to push the market studied in the future. According to the Department of Environment, Food and Rural Affairs' Farming Statistics 2018, the U.K. had 9.6 million cattle and calves in 2018. According to data provided by the United States Department of Agriculture, there were approximately 7.9 million cows and calves in Mexico in 2019, up from 7.7 million in 2018.

Other factors expected to fuel market expansion include increased spending on companion animals, increased availability of therapeutic choices for animals, and increased awareness in the region. Expanding adoption of companion animals and increased awareness of animal prostheses in countries like Spain, Germany, and Canada have enormous growth potential during the predicted period. 

Request a free sample copy or view report summary: Veterinary Prosthetics & Orthotics Market Report

Veterinary Prosthetics & Orthotics Market Report Highlights

• The veterinary prosthetics & orthotics market was valued at USD 32.3 million in 2021 and is expected to grow at a CAGR of 8.9% during the forecast period
• The rising prevalence and incidence of sports injuries and trauma in pet dogs is one of the key contributing factors to market growth
• The canine segment held the largest share of the market by product type in 2021. The key factors driving market expansion are technological advancements in prostheses and increased adoption rates
• In December 2020, L'il Back Bracer launched a new dog back orthotic called the Haute L'il Back Bracer which drives the market growth
• The technique segment was dominated by 3D printingin 2021 owing to the growing use of 3D printing
• 3D printing represented the largest share of the market in 2021 by technique

Access Press Release@ https://www.grandviewresearch.com/press-release/global-veterinary-prosthetics-orthotics-market

Veterinary Prosthetics & Orthotics Market Segmentation

Grand View Research has segmented the veterinary prosthetics & orthotics market based on type, animal type, technique, and region:

Product Type Outlook (Revenue, USD Million, 2017 - 2030)

• Orthotics
  • Stifle braces
  • Carpal/Tarsal braces
  • Others
• Prosthetics

Animal Type (Revenue, USD Million, 2017 - 2030)

• Canine
• Feline
• Others

Technique (Revenue, USD Million, 2017 - 2030)

• Molding
• 3D Printing

Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• ROW

List of Key Players in the Veterinary prosthetics & orthotics market

• OrthoPets LLC.
• Animal Ortho Care
• Handicapped Pets
• My Pet's Brace
• K-9 Orthotics & Prosthetics, Inc.
• DePuy Synthes
• Petsthetics
• Doggon Wheels
• Best Friend Mobility
• Movora

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Polyurethane Market Expected to Witness a Sustainable Growth over 2030: Grand View Research Inc.

 Polyurethane Market Growth & Trends 

The global polyurethane market size is expected to reach USD 105.45 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 4.3% from 2022 to 2030. The market is driven by the growing need for high-performance and lightweight composites in the automotive industry. The use of thermoplastic polyurethane (TPU) in car components has significantly reduced total vehicle weight. The automobile industry's need for plastics has been driven by the need to reduce total vehicle weight in order to reduce fuel consumption and carbon emissions. As an alternative to metals, PU is frequently utilized in automobile applications such as engine encapsulation, seats, external panels, instrument panels, external panels, and cables and wires.

Automobile manufacturers have been obliged to look for new ways to reduce fuel consumption as the Corporate Average Fuel Economy (CAFE) has increased. Due to the intrinsic relationship between mass and fuel consumption, light weight is a critical issue in these standards. Additionally, the reduction in mass at unfastened locations reduces noise and vibration while also smoothing the ride. Automobile manufacturers are primarily focused on car components made of various types of plastics in order to improve vehicle performance and follow the trend of lightweight vehicles.

Plastics are increasingly being used in automobile components such as automotive interiors, exterior panels, engine cabins, and instrument panels to improve fuel efficiency. Plastics can help reduce total vehicle weight and achieve the necessary fuel economy when used instead of metal components. This tendency, together with rising vehicle production, is predicted to boost polyurethane demand in applications such as engine encapsulation, outer body panels, and interior panels.

The COVID-19 pandemic had a significant impact on vehicle production and caused disruption throughout the automotive value chain. The market for polyurethane in automotive applications is projected to be impacted by a slowdown or standstill in production activity, negative consumer sentiments, and decreased consumer demand due to COVID-19.

During the forecast period, the electronics and appliances application segment is expected to increase at a significant rate. Protective coverings, printed circuit boards, electrical housings, and other items are made of polyurethane. While delivering outstanding general performance in electrical equipment, polyurethane enables cheaper unit costs and faster manufacturing. A key reason driving polyurethane demand in electronics and appliances is the growing relevance of encapsulating electronic components like circuits and sensors.

Request a free sample copy or view the report summary: Polyurethane Market Report

Polyurethane Market Report Highlights

• The rigid foam product segment accounted for the largest revenue share in 2021 and is expected to witness prominent growth during the forecast period
• The construction application segment dominated the global market and accounted for more than 25.0% share of the global revenue in 2021
• The Asia Pacific accounted for the largest revenue share of more than 40.0% in 2021. The strong manufacturing bases of the automotive, electronics, and appliances industries in China, India, South Korea, and Japan are expected to boost the market growth in the near future
• Over the last years, a number of strategic efforts have been implemented in order to improve market growth. For instance, on October 22, 2021, Huntsman International LLC launched a new range of low-emission MDI-based foam systems for automotive interiors; the ACOUSTIFLEX LE and RUBIFLEX LE polyurethane product lines. This product innovation enabled the automotive formulators and foam manufacturers to produce high-performance polyurethane foams, while significantly reducing interior emission levels

Access Press Release@ https://www.grandviewresearch.com/press-release/global-polyurethane-pu-market

Polyurethane Market Segmentation

Grand View Research has segmented the global polyurethane market based on product, application, and region:

Polyurethane Product Outlook (Volume, Kilotons, Revenue, USD Million, 2019 - 2030)

• Rigid Foam
• Flexible Foam
• Coatings
• Adhesives & Sealants
• Elastomers
• Others

Polyurethane Application Outlook (Volume, Kilotons, Revenue, USD Million, 2019 - 2030)

• Furniture & Interiors
• Construction
• Electronics & Appliances
• Automotive
• Footwear
• Packaging
• Others

Polyurethane Regional Outlook (Volume, Kilotons, Revenue, USD Million, 2019 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • Russia
  • Spain
  • UK.
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
• Central & South America
  • Brazil
• Middle East & Africa
  • Saudi Arabia

List of Key Players of the Global Polyurethane Market

• Dow Inc.
• BASF SE
• Covestro AG
• Huntsman International LLC
• Eastman Chemical Company
• Mitsui & Co. Plastics Ltd.
• Mitsubishi Chemical Corporation
• Recticel NV/SA
• Woodbridge
• DIC Corporation
• RTP Company
• The Lubrizol Corporation
• RAMPF Holding GmbH & Co. KG
• Tosoh Corporation

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Global Oral Care Market to Reach Around USD 58.5 Billion by 2030: Grand View Research Inc.

 Oral Care Market Growth & Trends

The global oral care market size is expected to reach USD 58.5 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.4% from 2022 to 2030. Growing cases of dental caries and rising awareness among people regarding oral hygiene have contributed to the market growth. According to FDI World Dental Federation, oral diseases affect around 3.5 billion people worldwide and it is estimated that around 2.3 billion people suffer from dental caries (tooth decay) of permanent teeth, globally. The lack of a proper diet is one of the leading factors contributing to the increase in the number of dental problems worldwide. Proper brushing of the teeth using toothpaste containing fluoride and a toothbrush can hinder dental problems to a significant extent, thereby creating demand for these products.   

Various awareness programs initiated by major players have led to increased awareness regarding oral hygiene among people of both developed as well as developing countries. For instance, the BRIGHT SMILES, BRIGHT FUTURES program by Colgate-Palmolive Company has been proactively involved in providing dental screenings and spreading oral health education with over billions of children and their families in many countries benefited from it. Thus, such support and initiatives have played a significant role in creating awareness among consumers worldwide about the importance of oral and dental hygiene. Furthermore, bringing new products into the market is another significant driver influencing the demand for oral care products. The launch of advanced products, such as powered toothbrushes and toothpaste, has transformed the market. In December 2020, P&G’s Crest, Oral-B, and Blend-a-med announced the launch of its first-ever recyclable high-density polyethylene toothpaste tubes in Europe and North America.

The COVID-19 pandemic has significantly affected the market. Initially, due to lockdown and global restrictions being imposed in most countries, many dental treatments and procedures were halted. The COVID-19 pandemic initially caused a massive disruption in the supply chain of the overall medical industry. However, leading personal care players such as Colgate-Palmolive Company; Johnson & Johnson Services, Inc.; and Procter & Gamble witnessed a rise in their sales from the oral care segment as consumer focus on hygiene is growing.

Request a free sample copy or view the report summary: Oral Care Market Report

Oral Care Market Report Highlights

• In 2021, the toothpaste product segment dominated the market with a revenue share of over 25.0% due to the increase in the number of people using different forms of toothpaste
• The toothbrush product segment is expected to grow at the fastest rate during the forecast period. The availability of a wide range of advanced and innovative products, such as battery-powered and electric toothbrushes, is fueling the segment growth
• The Asia Pacific held the largest market share in 2021 and is also projected to be the fastest-growing segment during the forecast period. This is due to the rising awareness about oral health among people in developing countries, such as India and China
• Leading players are coming up with easy-to-use and innovative oral care products, which has increased the adoption of oral care products at home

Access Press Release@ https://www.grandviewresearch.com/press-release/global-oral-care-market

Oral Care Market Segmentation

Grand View Research has segmented the global oral care market based on product, product type, application, distribution and region:

Oral Care Product Outlook (Revenue, USD Million, 2018 - 2030)

• Toothbrush           
  • Manual
  • Electric (Rechargeable)
  • Battery-powered (Non-rechargeable)
  • Others
• Toothpaste
  • Gel
  • Polish
  • Paste
  • Powder
• Mouthwash/Rinse
  • Medicated
  • Non-medicated
• Denture Products 
  • Cleaners
  • Fixatives
  • Floss
  • Others
• Dental Accessories          
  • Cosmetic Whitening Products
  • Fresh Breath Dental Chewing Gum
  • Tongue Scrapers
  • Fresh Breath Strips
  • Others
    • Oral Irrigators
    • Mouth Freshener Sprays

Oral Irrigator Product Type Outlook (Revenue, USD Million, 2018 - 2030)

• Countertop
• Cordless

Oral Irrigator Application Outlook (Revenue, USD Million, 2018 - 2030)

• Home
• Dentistry

Oral Irrigator Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Hypermarkets/Supermarkets
• Specialty Stores 
• Drug Stores & Pharmacies
• Convenience Stores
• Online Retailers
• Other Sales Channel

Oral Care Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Thailand
  • Malaysia
  • Singapore
  • Indonesia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of the Oral Care Market

• Procter & Gamble Company
• Johnson & Johnson Services, Inc.
• Colgate-Palmolive Company
• GlaxoSmithKline plc.
• Church & Dwight Co., Inc.
• Fresh, LLC
• Dentaid
• Lion Corporation
• Sunstar Suisse S.A.
• Henkel AG & Co. KGaA
• Unilever PLC
• DABUR INDIA LTD.
• ULTRADENT PRODUCTS

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Anti-drone Market Trends, Growth Prospects To 2030: Grand View Research Inc.

 Anti-drone Market Growth & Trends

The global anti-drone market size is anticipated to reach USD 10.5 billion by 2030, registering an estimated CAGR of 28.3% from 2022 to 2030, according to a new report by Grand View Research, Inc. The use of drones is getting more normal which increases the risk of security and privacy. These threats are faced by both civilians and military personnel as drones can be remotely operated and even unauthorized unmanned vehicles.

Sensitive military areas require anti-drone systems to protect them from any terrorism or illegal activities. The ease of access of small-sized drones has caused a significant increase in the market investment for the anti-drone equipment.

The sale of remote-controlled drones is legally based on location; however, there are many strict no-fly zones that the common public is unaware of. However, the threat of spy attacks and other types of attacks is higher for the regular public, military, and government.

The anti-drone market helps governments identify, locate, and destroy illegal drones either via software or direct launches. Government institutions, private enterprises, and military forces are the major clients of the anti-drone market. This market is also responsible for assisting the government in various public safety operations.

The anti-drone market uses a combination of modern technology and hardware in its product offerings. For instance, in October 2021, U.S. Homeland Security struck a deal with Drone Shield Ltd. and purchased drones with on the move attack technology from them. It has also been observed that the military also invests a large amount of money in the research and development of anti-drone systems making them a significant part of the anti-drone market.

The North American region generated the largest market share for the anti-drone market in 2021 as a direct result of the heavy investment in military and defense. It has been observed that multiple start-ups are providing custom and out of the box solutions in the anti-drone market.

Request a free sample copy or view report summary: Anti-drone Market Report

Anti-drone Market Report Highlights

• Due to the commercialization of drones, there has been an increase in small sized drones which are being used for illegal and/or terrorist activities
• The military and defense segments are investing heavily in the anti-drone market to counter the threat from unmanned aerial vehicles and other drone attacks
• Advancements in technologies in the anti-drone market allow users to bring down suspicious drones in one piece for further investigation and identification
• The anti-drone market in the Asia Pacific region is predicted to experience considerable growth as countries in that region are spending heavily on defense and military operations along with expansions

Access Press Release@ https://www.grandviewresearch.com/press-release/global-anti-drone-market

Anti-drone Market Segmentation

Grand View Research has segmented the global anti-drone market based on the  mitigation type, defense type, end use, and region:

Anti-drone Mitigation Type Outlook (Revenue, USD Billion, 2018 - 2030)

• Destructive System
  • Laser System
  • Missile Effector
  • Electronic Countermeasure
• Non-destructive System

Anti-drone Defence Type Outlook (Revenue, USD Billion, 2018 - 2030)

• Drone Detection & Disruption Systems
• Drone Detection Systems

Anti-drone End-Use Outlook (Revenue, USD Billion, 2018 - 2030)

• Military & Defence
• Commercial
• Government
• Others

Anti-drone Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
• Asia Pacific
  • China
  • Japan
• Latin America
• Middle East & Africa

List of the major players in the global Anti-drone Market include

• Advanced Radar Technologies S.A.
• Airbus Group SE
• Blighter Surveillance Systems
• Dedrone
• DeTect, Inc.
• Drone shield LLC
• Enterprise Control Systems
• Israel Aerospace Industries Ltd. (IAI)
• Lit eye Systems, Inc.
• Lockheed Martin Corporation
• Orelia
• Prime Consulting and technologies
• Raytheon Company
• Saab Ab
• Selex Es Inc.
• Thales Group
• The Boeing Company

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Pharmacovigilance And Drug Safety Software Market Factors Hindering The Growth Rate, Challenges and Restraints For Business Development 2030

 Pharmacovigilance And Drug Safety Software Market Growth & Trends

The global pharmacovigilance and drug safety software market size is anticipated to reach USD 17.4 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a lucrative CAGR of 10.5% from 2022 to 2030. The key factors driving the market growth include the increasing need to track and manage adverse drug reactions (ADR), comply with regulatory norms, increase adoption by end-users, interoperability, and product upgrades by key companies. In February 2022, Oracle’sArgus (for safety management) and Clinical One (for clinical trial management) were implemented by Clinixir—a Thailand-based CRO.

Various end-users such as pharmaceutical, and biotechnology companies, are adopting pharmacovigilance and drug safety software for cost reduction and minimizing operational expenses by gradually shifting from being fully integrated pharmaceutical companies to sharing costs by collaborating with service providers. Outsourcing helps increase internal resource flexibility, improves timelines, and results in better outcomes in the short as well as long term. Outsourcing also helps achieve better pharmacovigilance (PV) through regulatory compliance, higher quality, better productivity, and improved strategic outcomes. This is expected to fuel market growth.

Pharmacovigilance and drug safety software vendors, in an attempt to ensure sustainability, are providing customized and end-to-end solutions to meet consumer needs. These vendors are also incorporating integrated technologies such as electronic data capture, AI, and interoperability, among others to enhance their offerings. Moreover, the combined pressures of volume, cost, and heightened demand for analytics are propelling industry stakeholders to adopt advanced technology to support their pharmacovigilance activities. Also, the fact that service providers are now operating via a flexible and variable pricing structure and achieving operational excellence through constant product updates is expected to boost usage rates over the forecast period.

Request a free sample copy or view the report summary: Pharmacovigilance And Drug Safety Software Market Report

Pharmacovigilance And Drug Safety Software Market Report Highlights

• The market was valued at USD 6.7 billion in 2021 and is expected to expand at a CAGR of 10.5% during the forecast period
• By functionality, the signal management segment held the largest revenue share in 2021. This growth is driven by the increasing use of machine learning and AI in signal detection and reporting
• Based on delivery mode, the on-demand segment dominated the market in 2021. This is owing to the greater flexibility offered by an on-demand software in terms of price, functionality, and scalability
• Based on end-use, the CROs and BPO segments are slated to witness lucrative growth owing to increasing adoption by outsourcing companies to curb healthcare costs
• By region, North America dominated the market in 2021 while the APAC market is anticipated to grow the fastest in the coming years. Asian countries, especially India and China, are also expected to observe remarkable growth in the coming years
• The market is relatively competitive owing to the presence of global multinational players. It is also consolidated to a certain extent with large multinational companies holding a notable share of the market

Access Press Release@ https://www.grandviewresearch.com/press-release/global-pharmacovigilance-software-market

Pharmacovigilance And Drug Safety Software Market Segmentation

Grand View Research has segmented the global pharmacovigilance and drug safety software market based on functionality, delivery mode, end-use, and region:

Pharmacovigilance And Drug Safety Software Functionality Outlook (Revenue, USD Million, 2017 - 2030)

• Case Processing
• Signal Management
• Safety Metrics & Others

Pharmacovigilance And Drug Safety Software Delivery Mode Outlook (Revenue, USD Million, 2017 - 2030)

• On-Premise
• On-Demand

Pharmacovigilance And Drug Safety Software End-use Outlook (Revenue, USD Million, 2017 - 2030)

• Pharma & Biotech Companies
• CRO
• BPO
• Others

Pharmacovigilance And Drug Safety Software Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia

List of Key Players in the Pharmacovigilance And Drug Safety Software Market

• IQVIA
• Accenture
• Cognizant
• Laboratory Corporation of America Holdings
• IBM
• ArisGlobal
• ICON Plc.
• Capgemini
• Oracle
• Parexel International Corporation

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Real World Evidence Solutions Market to Reflect a Holistic Expansion During 2022 to 2030: Grand View Research Inc.

 Real World Evidence Solutions Market Growth & Trends

The global real world evidence solutions market size is expected to reach USD 78.80 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.1% from 2022 to 2030. The key factors driving the real world evidence (RWE) solutions market include favorable government regulations and a shift from volume to value-based care. Furthermore, the increasing prevalence of chronic disorders is anticipated to positively influence market growth.

During the pandemic, companies in the RWE solutions market diverted their focus on providing solutions for curbing the spread of COVID-19. For instance, IBM collaborated with Salesforce for building digital health passes, which incorporated data such as vaccine status, temperature checks, and COVID-19 test results for helping organizations to reopen safely. It also partnered with ServiceNow on Watson AIOps for supporting it to continue its leadership in transformative artificial intelligence by helping clients automate IT operations and reduce risks.

According to PerkinElmer, real world evidence solutions offer around USD 300 to 500 Billion in top-down opportunity for the U.S. healthcare industry alone. In addition, many life science companies are witnessing ad hoc value from selected RWE case studies and demonstrating around USD 100 million of bottom-up impact. Therefore, if a company captures USD 1 billion in real world evidence value, it ultimately creates more than USD tens of billions in terms of healthcare improvements. This is anticipated to boost the market growth.

The adoption and usage of RWE solutions are higher in developed markets of North America and Europe owing to supportive initiatives by legal, government, and other regulatory bodies. For instance, in October 2021, FDA selected the Aetion Evidence Platform to use RWE to analyze COVID-19 interventions and further regulatory science and innovation. Initiatives by regulatory agencies are supporting the expansion of RWE from post-market safety monitoring to other applications, such as for clinical trial design and observational studies and to substantiate coverage decisions.

Market players are investing in many strategic initiatives, such as acquisitions, mergers, partnerships, and product launches, to maintain a competitive edge in the market. For instance, in August 2021, Syneos Health partnered with Action for offering RWE solutions for advanced drug development and commercialization. This partnership brought together Syneos Health’s proprietary data collection research solutions and Aetion’s Evidence platform, AEP, for generating evidence through patient data curation and real world data.

Request a free sample copy or view the report summary: Real World Evidence Solutions Market Report

Real World Evidence Solutions Market Report Highlights

• Favorable government initiatives and a shift from volume to value-based care are expected to boost the market growth
• The services component segment led the market in 2021 owing to its increasing demand over the forecast period
• The drug development and approvals application segment dominated the market in 2021 owing to the rising adoption of RWE solutions in pharmaceutical companies for this application
• The healthcare payers' end-user segment is anticipated to expand at the fastest CAGR over the forecast period owing to the increasing awareness among payers regarding drug and medical device safety
• North America led the global market in 2021 with a revenue share of more than 40.0% owing to the presence of major players in the region
• Asia Pacific is expected to be the fastest-growing regional market from 2022 to 2030 owing to the presence of contract research organizations in the region
• The market is fairly competitive. For instance, in April 2021, Thermo Fisher Scientific announced that it is set to acquire PPD, Inc. for USD 47.50 per share

Access Press Release@ https://www.grandviewresearch.com/press-release/global-real-world-evidence-solutions-market

Real World Evidence Solutions Market Segmentation

Grand View Research has segmented the global real world evidence (RWE) solutions market based on component, application, end-user, and region:

Real World Evidence (RWE) Solutions Component Outlook (Revenue, USD Million, 2017 - 2030)

• Services
• Data Sets
  • Clinical Settings Data
  • Claims Data
  • Pharmacy Data
  • Patient-Powered Data

Real World Evidence Solutions Application Outlook (Revenue, USD Million, 2017 - 2030)

• Drug Development & Approvals
• Medical Device Development & Approvals
• Reimbursement/Coverage & Regulatory Decision Making
• Post Market Safety & Adverse Events Monitoring

Real World Evidence Solutions End-user Outlook (Revenue, USD Million, 2017 - 2030)

• Pharmaceutical & Medical Device Companies
• Healthcare Providers
• Healthcare Payers
• Others

Real World Evidence Solutions Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • Israel

List of Key Players of Real World Evidence Solutions Market

• IQVIA
• IBM
• PPD Inc.
• Parexel Internation Corporation
• PerkinElmer Inc.
• Icon Plc
• Oracle
• Syneos Health
• Cegedim Health Data
• Medpace

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.